Holzer Ralf, Beekman Robert, Benson Lee, Bergersen Lisa, Jayaram Natalie, Jenkins Kathy, Kennedy Kevin, Moore John, Ringel Richard, Rome Jonathan, Vincent Robert, Martin Gerard R
1Sidra Medical & Research Center,Doha,Qatar.
2Cincinnati Children's Hospital,Cincinnati,United States of America.
Cardiol Young. 2016 Aug;26(6):1202-12. doi: 10.1017/S1047951115002218. Epub 2015 Oct 12.
The objective of this study was to report procedural characteristics and adverse events on the data collected in the IMproving Paediatric and Adult Congenital Treatment registry.
The IMproving Paediatric and Adult Congenital Treatment- registry is a catheterisation registry focussed on paediatric and adult patients with congenital heart disease who are undergoing diagnostic catheterisations and catheter-based interventions. This study reports procedural characteristics and adverse events of patients who have undergone selected catheterisation procedures from January, 2011 to June, 2013.
Demographic, clinical, procedural, and institutional data elements were collected at participating centres and entered via either a web-based platform or software provided by the American College of Cardiology-certified vendors, and were collected in a secure, centralised database. For the purpose of this study, procedures that were not classified as one of the 'core' IMproving Paediatric and Adult Congenital Treatment procedures originally chosen for additional data collection were identified and selected for further data analysis.
During the time frame of data collection, a total of 8021 cases were classified as other procedures and/or multiple procedures. The most commonly performed case types - isolated or in combination with other procedures - were right ventricular biopsy in 3433 (42.8%), conduit/MPA interventions in 979 (12.3%), and systemic pulmonary artery collateral occlusion in 601 (7.5%). For the whole cohort, adverse events of any severity occurred in 957 (12.0%) cases, whereas major adverse events occurred in 113 (1.4%) cases; six patients (0.1%) died in the catheterisation laboratory.
The IMproving Paediatric and Adult Congenital Treatment registry has provided important data on the frequency and spectrum of cardiac catheterisation procedures performed in the present era. For many procedures, more data and work are needed to identify more subtle differences between case categories, especially as it relates to the incidence of major adverse events, and to further develop a risk-adjustment methodology to allow equitable comparisons among institutions.
本研究的目的是报告在改善儿科和成人先天性心脏病治疗登记处收集的数据中的手术特征和不良事件。
改善儿科和成人先天性心脏病治疗登记处是一个导管插入术登记处,专注于接受诊断性导管插入术和基于导管的干预措施的儿科和成人先天性心脏病患者。本研究报告了2011年1月至2013年6月期间接受选定导管插入术的患者的手术特征和不良事件。
在参与中心收集人口统计学、临床、手术和机构数据元素,并通过基于网络的平台或美国心脏病学会认证供应商提供的软件输入,这些数据被收集到一个安全的集中数据库中。为了本研究的目的,识别并选择了最初未被归类为“核心”改善儿科和成人先天性心脏病治疗程序之一(这些程序最初被选择用于额外的数据收集)的程序,以进行进一步的数据分析。
在数据收集期间,共有8021例病例被归类为其他程序和/或多种程序。最常进行的病例类型(单独或与其他程序联合)是右心室活检3433例(42.8%)、导管/主肺动脉干预979例(12.3%)和体肺侧支血管闭塞601例(7.5%)。在整个队列中,957例(12.0%)发生了任何严重程度的不良事件,而主要不良事件发生在113例(1.4%);6例患者(0.1%)在导管插入实验室死亡。
改善儿科和成人先天性心脏病治疗登记处提供了关于当代心脏导管插入术程序的频率和范围的重要数据。对于许多程序,需要更多的数据和工作来识别病例类别之间更细微的差异,特别是与主要不良事件的发生率相关的差异,并进一步开发风险调整方法,以便在各机构之间进行公平比较。